Tilray Brands (TLRY) Net Income (QoQ) (2017 - 2026)
Tilray Brands (TLRY) Net Income (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.15 Bn | 20.99 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.17 Bn | 21.17 Bn | - |
| 7 | Viatris | 20.32 Bn | 18.51 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.42 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn |
| 10 | Tilray Brands | 456.34 Mn | 396.14 Mn | 54.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 42.01% |
| Nov 30, 2025 | -2,975.68% |
| Aug 31, 2025 | 100.11% |
| May 31, 2025 | -75.59% |
| Feb 28, 2025 | -830.56% |
| Nov 30, 2024 | -146.09% |
| Aug 31, 2024 | -150.93% |
| May 31, 2024 | 164.81% |
| Feb 29, 2024 | -127.32% |
| Nov 30, 2023 | 17.33% |
| Aug 31, 2023 | -106.84% |
| May 31, 2023 | 168.27% |
| Feb 28, 2023 | -1,305.76% |
| Nov 30, 2022 | -29.28% |
| Aug 31, 2022 | 73.77% |
| May 31, 2022 | -577.99% |
| Feb 28, 2022 | 805.21% |
| Nov 30, 2021 | 116.75% |
| Aug 31, 2021 | -110.00% |
| May 31, 2021 | 233.74% |